LSTA
LISATA THERAPEUTICS, INC.
+0.28 (+19.05%)1.75USD2.2M成交股數15.8M市值–本益比(近四季)157.7股價營收比-100.0%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0-100% | 0 | – | 0 | 70K | 0 | – | 0 | 0 | 0 | 0 | 0 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 584K | 1.2M | – | 2.0M | 2.3M | 2.6M | – | 2.5M | 2.6M | 3.2M | 3.0M | 3.4M |
| 銷售管理費用 | 3.4M | 3.7M | – | 2.5M | 2.7M | 3.2M | – | 2.8M | 2.9M | 3.4M | 3.0M | 2.6M |
| 營業利益 | −4.0M-18% | −4.9M-15% | – | −4.4M-17% | −4.9M-12% | −5.8M-11% | – | −5.3M-11% | −5.5M | −6.6M | −6.0M | −6.0M |
| 營業利益率 | – | – | – | – | -6,954.3% | – | – | – | – | – | – | – |
| 稅後淨利 | −2.9M-37% | −4.5M-5% | – | −4.2M-14% | −4.7M-8% | −4.7M-13% | – | −4.9M-6% | −5.0M | −5.4M | −5.4M | −5.3M |
| 淨利率 | – | – | – | – | -6,655.7% | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.32-41% | -0.50-9% | – | -0.49-17% | -0.54-11% | -0.55-15% | – | -0.59-9% | -0.61 | -0.65 | -0.66 | -0.65 |
| 稀釋股數 | 9.1M | 9.0M | – | 8.7M | 8.6M | 8.6M | – | 8.3M | 8.3M | 8.3M | 8.1M | 8.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 10.4M | 13.1M | – | 19.0M | 16.8M | 20.2M | – | 19.5M | 28.3M | 21.8M | 22.6M | 32.4M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | 0 | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 11.0M | 14.1M | – | 21.8M | 25.2M | 29.0M | – | 38.2M | 42.6M | 48.2M | 54.7M | 58.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 3.0M | 3.4M | – | 4.6M | 4.4M | 3.9M | – | 4.8M | 4.6M | 5.5M | 6.8M | 5.4M |
| 股東權益 | 8.2M | 10.9M | – | 17.4M | 21.0M | 25.4M | – | 33.7M | 38.2M | 43.0M | 48.1M | 53.0M |
| 負債比 | 27.5% | 24.1% | – | 21.3% | 17.4% | 13.4% | – | 12.5% | 10.7% | 11.4% | 12.4% | 9.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.1M-43% | – | – | – | −5.4M-23% | – | – | – | −7.0M | – | – |
| 資本支出 | – | 0 | – | – | – | 28K | – | – | – | 0 | – | – |
| 自由現金流 | – | −3.1M-43% | – | – | – | −5.4M-23% | – | – | – | −7.0M | – | – |
| 折舊攤銷 | 3K | 2K | – | 44K | 44K | 43K | – | 42K | 45K | 46K | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 170K
| Reportable | 170K | 100.0% | -83.0% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 170K | -83.0% | −16.6M | -9,756.5% | -1.91 | −16.0M |
| FY2024 | 1.0M | – | −20.0M | -1,998.5% | -2.40 | −19.4M |
| FY2023 | 0 | – | −20.8M | –% | -2.58 | −20.0M |
| FY2022 | 0 | – | −54.2M | –% | -10.47 | −21.5M |
| FY2021 | – | – | −27.5M | –% | -7.45 | −22.3M |
| FY2020 | – | – | −8.2M | –% | -0.53 | −8.8M |
| FY2019 | – | – | −19.4M | –% | -1.88 | −18.9M |
| FY2018 | – | – | −16.2M | –% | -1.67 | −20.1M |